MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation - An immunohistochemical study

Gynecologic Oncology

Volumn 84, Issue 2, 2002, Pages 222-227

  Brummer, Oliver ^a   Böhmer, Gerd ^a   Hollwitz, Bettina ^a   Flemming, Peer ^a   Petry, K Ulrich ^a   Kühnle, Henning ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cervical intraepithelial neoplasia; Extracellular matrix; HPV; Matrix degradation; MMP

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; ENZYME DEGRADATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STROMA CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0036173281     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6413     Document Type: Article

References (39)

1. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
2. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
3. Metalloproteinases and their inhibitors in tissue remodeling
4. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix
5. Control of matrix metalloproteinase activity in cancer
6. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
7. Molecular aspects of tumor cell invasion and metastasis
8. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
9. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity
10. Human 72 kDa type IV collagenase forms a complex with a tissue inhibitor of metalloproteinase designated TIMP-2
11. The matrix metalloproteinases and their inhibitors
12. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathological study using immuohistochemistry and mRNA in situ hybridization
13. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma
14. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TLMP-2 in neoplastic tissues with monoclonal antibodies
15. r 72,000 type IV collagenase in human colonic adenocarcinoma
16. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue
17. Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: An in situ hybridization study
18. Stromal expression of 72 kDa type IV collagenase (MMP2) and TIMP2 m-RNAs in colorectal neoplasia
19. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
20. Gelatinase A expression and localization in human breast cancer. An in situ hybridization study and immunohistochemical detection using confocal microscopy
21. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
22. Prognosis of gastric carcinoma revealed by interactions betwen tumor cells and basement membrane
23. Production of matrix metalloproteinase-2 metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study
24. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT1-MMP) and with lymph node metastasis
25. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic turnout progression and may have prognostic value
26. Human papillomaviruses
27. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
28. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998
29. Tissue inhibitor of metalloproteinases-1 and -2 expression in rat and human liver fibrosis
30. Structure of human type IV collagenase gene
31. Urukinase-type plasminogen activator antigene and early relapse in breast cancer
32. Loss of basement membrane components by invasive tumors but not by their non-invasive counterparts
33. Expression of gelatine A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas
34. Collagenases immunolocalisation studies of rheumatoid and malignant tissue
35. Expression of matrix metaloproteinase-9 in squamous cell carcinoma of the uterine cervix - Clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
36. Genes of laminin B1 chain, α1 (IV) chain of type IV collagene and 70 kDa type IV collagenase are mainly expressed by the stromal cells of lung carcinomas
37. Expression of 72 kDa type IV collagenase in benign and malignant ovarian tumors
38. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor
39. Human papillomavirus and screening for cervical cancer: State of the art and prospects